BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19072486)

  • 1. Considerations for the antiretroviral management of women in 2008.
    Clark R
    Womens Health (Lond); 2008 Sep; 4(5):465-77. PubMed ID: 19072486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of gender and pregnancy on antiretroviral therapy for HIV: pharmacokinetic and disease-related differences.
    Scarsi KK; Postelnick MJ
    J Gend Specif Med; 2003; 6(1):7-16. PubMed ID: 12661172
    [No Abstract]   [Full Text] [Related]  

  • 3. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guide addresses unique aspects of care for women with HIV.
    Rollins G
    Rep Med Guidel Outcomes Res; 2001 Jul; 12(14):10, 12. PubMed ID: 12214620
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship of pregnancy to the use of highly active antiretroviral therapy.
    Minkoff H; Ahdieh L; Watts H; Greenblatt RM; Schmidt J; Schneider M; Stek A
    Am J Obstet Gynecol; 2001 May; 184(6):1221-7. PubMed ID: 11349192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi.
    Weigel R; Hosseinipour MC; Feldacker C; Gareta D; Tweya H; Chiwoko J; Gumulira J; Kalulu M; Mofolo I; Kamanga E; Mwale G; Kadzakumanja A; Jere E; Phiri S
    Trop Med Int Health; 2012 Jun; 17(6):751-9. PubMed ID: 22487553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance.
    Grant PM; Zolopa AR
    Curr Opin Investig Drugs; 2010 Aug; 11(8):901-10. PubMed ID: 20721832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects of antiretrovirals in HIV-infected pregnant women.
    Zuk DM; Hughes CA; Foisy MM; Robinson JL; Singh AE; Houston S
    Ann Pharmacother; 2009 Jun; 43(6):1028-35. PubMed ID: 19491318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The feminization of an epidemic. Women and HIV in the United States.
    Iobst S; Gandhi M
    Posit Aware; 2009; 20(4):34-9. PubMed ID: 19653375
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiretroviral treatment during pregnancy.
    Keiser O; Gayet-Ageron A; Rudin C; Brinkhof MW; Gremlich E; Wunder D; Drack G; Hirschel B; de Tejada BM; ;
    AIDS; 2008 Nov; 22(17):2323-30. PubMed ID: 18981771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women and HIV.
    Laurence J
    AIDS Read; 2007 Dec; 17(12):574, 580. PubMed ID: 18178972
    [No Abstract]   [Full Text] [Related]  

  • 16. Conferences raise new questions about HAART use by women.
    Hanna L
    BETA; 1999; 12(4):30-9, 53. PubMed ID: 11367248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
    Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiretroviral-experienced patient.
    Clark RA; Wilcox R; Besch CL
    Am J Med Sci; 2004 Jul; 328(1):10-6. PubMed ID: 15254437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-specific considerations in the antiretroviral management of HIV-infected women.
    Clark RA; Squires KE
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):213-27. PubMed ID: 15918779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
    Short CE; Douglas M; Smith JH; Taylor GP
    HIV Med; 2014 Apr; 15(4):233-8. PubMed ID: 24025074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.